GYRE
USDGyre Therapeutics Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$7.470
Haut
$7.470
Bas
$7.250
Volume
0.06M
Fondamentaux de l'Entreprise
Capitalisation Boursière
662.1M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
0.09M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Gyre Therapeutics Announces Completion of Patient Enrollment in Phase 3 Clinical Trial of Pirfenidone Capsules for the Treatment of Pneumoconiosis
SAN DIEGO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (NASDAQ:GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by
Gyre Therapeutics to Present Results from Positive Phase 3 Clinical Trial Evaluating Hydronidone for the Treatment of Liver Fibrosis in Chronic Hepatitis B at AASLD—The Liver Meeting® 2025
SAN DIEGO, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics ("Gyre") (NASDAQ:GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems
Jefferies Initiates Coverage On Gyre Therapeutics with Buy Rating, Announces Price Target of $16
Jefferies analyst Roger Song initiates coverage on Gyre Therapeutics with a Buy rating and announces Price Target of $16.
Actions Connexes
TBLD
Thornburg Income Builder Opportunities Trust
DHCNL
Diversified Healthcare Trust 6.25% Senior Notes Due 2046
MODG
Topgolf Callaway Brands Corp.
CEP
Cantor Equity Partners Inc. Ordinary Shares
MOBXW
Mobix Labs Inc Warrants
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.